tiprankstipranks
ICOA Inc (ICOA)
OTHER OTC:ICOA
US Market

ICOA (ICOA) Income Statement

16 Followers

ICOA Income Statement

Last quarter (Q ), ICOA's total revenue was $20.92K, a decrease of -9.75% from the same quarter last year. In Q, ICOA's net income was $-379.71K. See ICOA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 14Dec 13Dec 12Dec 11Dec 05
Total Revenue
$ 86.58K$ 88.84K$ 109.97K$ 125.21K$ 85.22K$ 2.48M
Cost of Revenue
$ 108.45K$ 125.88K$ 133.65K$ 201.63K$ 7.24K$ 2.46M
Gross Profit
$ -21.87K$ -37.04K$ -23.68K$ -76.43K$ 77.99K$ 20.34K
Operating Expense
$ 263.43K$ 274.21K$ 317.42K$ 521.76K$ -757.05K$ 4.28M
Operating Income
$ -285.30K$ -311.25K$ -341.10K$ -598.19K$ 835.04K$ -4.26M
Net Non Operating Interest Income Expense
$ -976.19K$ -865.55K$ -848.51K$ -1.65M$ -477.32K-
Other Income Expense
-$ 98.59K$ 16.51K$ -31.02K$ 667.94K$ -66.99K
Pretax Income
$ -1.26M$ -1.08M$ -1.17M$ -2.28M$ 1.03M-
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -1.26M$ -1.08M$ -1.17M$ -2.28M$ 1.03M$ -9.24M
Basic EPS
-$ >-0.01$ >-0.01$ >-0.01$ <0.01$ -150.00
Diluted EPS
-$ >-0.01$ >-0.01$ >-0.01$ <0.01$ -150.00
Basic Average Shares
$ 33.93B$ 8.48B$ 8.48B$ 8.48B$ 4.56B$ 54.62K
Diluted Average Shares
$ 33.93B$ 8.48B$ 8.48B$ 8.48B$ 4.56B$ 70.78K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 371.88K$ 400.09K$ 451.07K$ 723.39K$ -749.81K$ 6.73M
Net Income From Continuing And Discontinued Operation
$ -1.26M$ -1.08M$ -1.17M$ -2.28M$ 1.03M$ -9.24M
Normalized Income
$ -1.26M$ -1.18M$ -1.19M$ -2.25M$ 591.50K$ -9.17M
Interest Expense
$ 976.19K$ 865.55K$ 848.51K$ 1.65M$ 477.32K-
EBIT
$ -285.30K$ -212.66K$ -324.59K$ -629.21K$ 1.50M$ -4.26M
EBITDA
$ -285.30K$ -212.66K$ -322.89K$ -626.94K$ 1.50M$ -3.28M
Currency in USD

ICOA Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis